Drug/chemical-induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral, is a serious complication of diabetes that can lead to vision loss. This condition arises from the effects of certain medications or chemicals that induce diabetes, resulting in retinal damage characterized by abnormal blood vessel growth. Accurate coding with ICD-10 Code E09.3593 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
ICD-10 Code E09.3593 represents drug or chemical-induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral. This code is used when a patient develops diabetes as a result of medication or chemical exposure, leading to severe retinal complications. It should be applied in clinical documentation and billing when the patient presents with these specific conditions, ensuring accurate representation of the patient's health status.
Drug/chemical-induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral, is primarily caused by certain medications or toxic substances that disrupt normal glucose metabolism. This condition can progress to significant visual impairment if not managed promptly, necessitating medical intervention.
ICD-10 Code E09.3593 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to drug/chemical-induced diabetes and its complications. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management.
In SOAP notes, ICD-10 Code E09.3593 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of drug/chemical-induced diabetes with proliferative diabetic retinopathy. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Prompt treatment is crucial for managing drug/chemical-induced diabetes with proliferative diabetic retinopathy to prevent vision loss.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E09.3593 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity. |
| 92014 | Ophthalmological examination, comprehensive, established patient. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code E09.3593 for Drug/chem diab with prolif diab rtnop without mclr edema, bi
What medications can cause drug-induced diabetes?
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can induce diabetes by affecting insulin sensitivity or secretion.
How is proliferative diabetic retinopathy treated?
Treatment options include laser photocoagulation therapy, anti-VEGF injections, and vitrectomy, depending on the severity of the condition.
What are the symptoms of proliferative diabetic retinopathy?
Symptoms may include blurred vision, floaters, and difficulty seeing at night, often indicating retinal damage.
Is E09.3593 used for acute or chronic conditions?
ICD-10 Code E09.3593 is applicable for both acute and chronic management of drug-induced diabetes and its complications.
Clinical Notes
SOAP notes
DAP notes
AI medical notes